Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial.

M, Barret; M, Pioche; B, Terris; T, Ponchon; F, Cholet; F, Zerbib; E, Chabrun; Rhun M, Le; E, Coron; M, Giovannini; F, Caillol; R, Laugier; J, Jacques; R, Legros; C, Boustiere; G, Rahmi; E, Metivier-Cesbron; G, Vanbiervliet; P, Bauret; J, Escourrou; J, Branche; L, Jilet; H, Abdoul; N, Kaddour; S, Leblanc; M, Bensoussan; F, Prat; S, Chaussade

doi:10.1136/gutjnl-2020-322082

Public

Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial.

Shared by NobleBlocks on Mar 8, 2021 • 12:00 AM UTC

Authors:

Barret M

Pioche M

Terris B

Abstract

<h4>Objective</h4>Due to an annual progression rate of Barrett's oesophagus (BO) with low-grade dysplasia (LGD) between 9% and 13% per year endoscopic ablation therapy is preferred to surveillance. Since this recommendation is based on only one randomised trial, we aimed at checking these results by...

Subject

Dysplasia

Barrett's Oesophagus

Endoscopic Procedures

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!